Veeva Systems Inc. (VEEV)
NYSE: VEEV · Real-Time Price · USD
225.79
-2.95 (-1.29%)
Feb 21, 2025, 4:00 PM EST - Market closed
Veeva Systems Market Cap
Veeva Systems has a market cap or net worth of $36.66 billion as of February 21, 2025. Its market cap has increased by 8.76% in one year.
Market Cap
36.66B
Enterprise Value
31.67B
1-Year Change
8.76%
Ranking
Category
Stock Price
$225.79
Market Cap Chart
Since October 16, 2013, Veeva Systems's market cap has increased from $4.54B to $36.66B, an increase of 706.91%. That is a compound annual growth rate of 20.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 36.66B | 7.39% |
| Dec 31, 2024 | 34.13B | 10.11% |
| Dec 29, 2023 | 31.00B | 23.38% |
| Dec 30, 2022 | 25.13B | -36.04% |
| Dec 31, 2021 | 39.28B | -4.74% |
| Dec 31, 2020 | 41.24B | 97.30% |
| Dec 31, 2019 | 20.90B | 61.04% |
| Dec 31, 2018 | 12.98B | 66.10% |
| Dec 29, 2017 | 7.81B | 39.96% |
| Dec 30, 2016 | 5.58B | 45.50% |
| Dec 31, 2015 | 3.84B | 11.25% |
| Dec 31, 2014 | 3.45B | -13.77% |
| Dec 31, 2013 | 4.00B | -11.95% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.17B |
| UnitedHealth Group | 428.92B |
| Johnson & Johnson | 391.09B |
| Novo Nordisk | 370.84B |
| AbbVie | 357.89B |
| Abbott Laboratories | 234.03B |
| AstraZeneca | 229.50B |
| Merck & Co. | 225.13B |